Parschauer Karah Herdman

The estimated Net Worth of Parschauer Karah Herdman is at least $2 Million dollars dollars as of 05/18/2022. Parschauer Karah Herdman is the EVP and Chief Legal Officer of Ultragenyx Pharmaceutical Inc. Parschauer Karah Herdman owns over 34,438 shares of Ultragenyx Pharmaceutical Inc stock worth over $2 Million dollars .

Parschauer Karah Herdman mailing address: 60 LEVERONI COURT NOVATO CA 94949

Insider Roles

Name Transaction Date Position
Ultragenyx Pharmaceutical Inc 2017-03-01 officer: EVP and General Counsel
Arcturus Therapeutics Holdings Inc 2019-06-19 director
Evolus Inc 2019-07-15 director
Anebulo Pharmaceuticals Inc 2021-05-06 director
Tenaya Therapeutics Inc 2021-12-22 director
EMBED
SAVE

Parschauer Karah Herdman trading transactions

Ticker Company Current Price Insider Name Insider Position Date Buy/Sell Insider Trading Shares Shares Change Price Cost Final Share Price Change Since Insider Trade (%) Filing Date Dividend Yield % PE Ratio Market Cap ($M)
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and Chief Legal Officer
2022-03-07 Sell
5,140
-12.99%
$62.95
$323,563
34,438
-21.62%
2022-03-08
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and Chief Legal Officer
2022-03-01 Sell
2,886
-6.80%
$66.62
$192,265
39,578
-25.94%
2022-03-03
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and General Counsel
2021-09-08 Sell
7,336
-20.38%
$100.65
$738,368
28,668
-50.98%
-
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and General Counsel
2021-06-10 Sell
1,329
-4.43%
$100
$132,900
28,668
-50.66%
-
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and General Counsel
2021-03-01 Sell
3,970
-11.61%
$138.17
$548,535
30,227
-64.29%
-
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and General Counsel
2020-10-30 Sell
9,903
-29.16%
$100.12
$991,488
24,061
-50.72%
-
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and General Counsel
2020-10-08 Sell
10,000
-29.16%
$95
$950,000
24,293
-48.06%
-
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and General Counsel
2020-10-06 Sell
10,000
-29.16%
$90
$900,000
24,293
-45.18%
-
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and General Counsel
2020-09-23 Sell
10,000
-29.16%
$85
$850,000
24,293
-41.95%
-
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and General Counsel
2020-08-17 Sell
12,370
-33.74%
$88.43
$1,093,880
24,293
-44.20%
-
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and General Counsel
2020-05-18 Sell
2,722
-9.06%
$74.72
$203,388
27,312
-33.97%
-
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and General Counsel
2019-06-24 Sell
2,715
-13.33%
$62.33
$169,226
17,650
-20.84%
-
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and General Counsel
2018-08-21 Sell
5,000
-26.07%
$78.53
$392,650
14,181
-37.17%
-
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and General Counsel
2018-08-21 Sell
5,000
-35.26%
$78.53
$392,650
9,181
-37.17%
-
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and General Counsel
2018-06-21 Sell
1,226
-7.96%
$82.77
$101,476
14,181
-40.39%
-
0
At Loss
3,480.43
RARE
Ultragenyx Pharmaceutical Inc
$49.34
Parschauer Karah Herdman
EVP and General Counsel
2018-05-10 Sell
1,465
-8.36%
$60
$87,900
16,056
-17.77%
-
0
At Loss
3,480.43
Total 16
  • 1

Parschauer Karah Herdman personal network

Name Position Linked company